About this trial
Anxiety disorders commonly begin during adolescence, and are characterized by deficits in the ability to inhibit or extinguish pathological fear. Recent research has provided new understanding of how fear is learned and can be regulated in the adolescent brain, and how the endocannabinoid system shapes these processes; however, these advances have not yet translated into improved therapeutic outcomes for adolescents with anxiety. This study will test whether a behavioral intervention, acute exercise, can help to improve fear regulation by enhancing brain activity and endocannabinoid signaling. This line of research may ultimately lead to more effect treatments for adolescent anxiety, and to new preventive strategies for at-risk youth.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and available for the duration of the study
14-17 years of age upon enrollment
Right-handed
Disqualifiers
Traumatic brain injury with ongoing symptoms
Sensory (e.g., hearing) or physical (e.g., motor, balance) impairment or significant developmental delay
MRI participants: MRI contraindication (e.g., braces, implants, claustrophobia)
Any condition that would contraindicate blood draws (e.g., hemophilia, sickle cell)
Trial design
Treatments tested in this trial
- Moderate Intensity Exercise
Treatment groups
Sponsors and collaborators
Wayne State University
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator